News & Updates

Altered measures of the coagulation parameters, specifically high international normalised ratio and low haemoglobin, in the third trimester of pregnancy among women with severe anaemia appear to contribute to an increased risk of postpartum haemorrhage, a study has found.

The antimigraine medications dihydroergotamine (DHE) and triptan seem to aggravate the risk of adverse pregnancy outcomes such as premature birth and spontaneous abortion (SA), a recent study has found.

Among women receiving immunosuppression treatment with mammalian target of rapamycin inhibitors (mTORi), the incidence of ovarian cyst appears to be a common adverse event, according to the results of a systematic review and meta-analysis.

Extending treatment with letrozole for 5 years improves disease-free survival (DFS) rates in postmenopausal women with early-stage breast cancer who have already received tamoxifen for 2–3 years, according to the GIM4* trial.

In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.

Oteseconazole (VT-1161), a novel investigational fungal CYP51 inhibitor, outdid fluconazole/placebo for managing acute and recurrent* vulvovaginal candidiasis (VVC), according to data from the phase III ultraVIOLET trial.

Among women with gestational diabetes mellitus, microalbuminuria may occur in the third trimester despite exposure to only a brief period of overt hyperglycaemia, a study has found.

Cervical adenocarcinoma has at least a 50 percent survival rate which can be further improved by early diagnosis and individualized and comprehensive treatment, a recent study has found.